Dr. Fauci on FDA authorization of Moderna and Johnson & Johnson boosters, and ability to switch vaccine brands




Pfizer booster has 95.6% efficacy against COVID, large study shows

A booster shot of the Pfizer-BioNTech vaccine is 95.6% effective against the coronavirus, compared with those who only had the first two initial doses, according to a large study released Thursday.Why it matters: The study, which had more than 10,000 participants aged 16 and older, is the first controlled, randomized trial looking at boosters and their effectiveness, the companies said.Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for freeThe compani


Source link